California Public Employees Retirement System lessened its position in Balchem Co. (NASDAQ:BCPC – Get Rating) by 0.6% during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 72,113 shares of the basic materials company’s stock after selling 439 shares during the quarter. California Public Employees Retirement System owned approximately 0.22% of Balchem worth $9,858,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Stephens Investment Management Group LLC raised its position in Balchem by 1.4% in the 1st quarter. Stephens Investment Management Group LLC now owns 320,085 shares of the basic materials company’s stock valued at $43,756,000 after buying an additional 4,457 shares during the last quarter. Victory Capital Management Inc. raised its position in Balchem by 84.2% in the 1st quarter. Victory Capital Management Inc. now owns 6,772 shares of the basic materials company’s stock valued at $834,000 after buying an additional 3,095 shares during the last quarter. Martin & Co. Inc. TN raised its position in Balchem by 2.0% in the 1st quarter. Martin & Co. Inc. TN now owns 18,386 shares of the basic materials company’s stock valued at $2,513,000 after buying an additional 360 shares during the last quarter. Mutual of America Capital Management LLC raised its position in Balchem by 5.5% in the 1st quarter. Mutual of America Capital Management LLC now owns 4,666 shares of the basic materials company’s stock valued at $638,000 after buying an additional 242 shares during the last quarter. Finally, Nisa Investment Advisors LLC acquired a new stake in Balchem in the 1st quarter valued at approximately $784,000. Institutional investors and hedge funds own 89.60% of the company’s stock.
Balchem Stock Up 0.6 %
BCPC stock opened at $127.51 on Friday. The company has a quick ratio of 1.64, a current ratio of 2.62 and a debt-to-equity ratio of 0.50. The business has a 50 day moving average price of $126.33 and a two-hundred day moving average price of $131.25. The company has a market cap of $4.10 billion, a price-to-earnings ratio of 38.18 and a beta of 0.59. Balchem Co. has a twelve month low of $110.15 and a twelve month high of $174.29.
Insider Buying and Selling at Balchem
In other Balchem news, VP Gunsteren Job Leonard Van sold 3,601 shares of the firm’s stock in a transaction that occurred on Wednesday, August 3rd. The stock was sold at an average price of $125.62, for a total value of $452,357.62. Following the completion of the transaction, the vice president now directly owns 1,430 shares in the company, valued at $179,636.60. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 1.54% of the company’s stock.
Analysts Set New Price Targets
BCPC has been the topic of a number of recent research reports. StockNews.com lowered Balchem from a “buy” rating to a “hold” rating in a research report on Monday, August 1st. HC Wainwright decreased their price target on Balchem from $155.00 to $152.00 and set a “buy” rating for the company in a research note on Monday, May 2nd.
Balchem Profile
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.
Featured Articles
Receive News & Ratings for Balchem Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Balchem and related companies with MarketBeat.com’s FREE daily email newsletter.
